Seok-Chul Yang

2.0k total citations
23 papers, 1.6k citations indexed

About

Seok-Chul Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Seok-Chul Yang has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Seok-Chul Yang's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Seok-Chul Yang is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Seok-Chul Yang collaborates with scholars based in South Korea, United States and Switzerland. Seok-Chul Yang's co-authors include Steven M. Dubinett, Sherven Sharma, Karen L. Reckamp, Felicita Baratelli, Raj K. Batra, Min Huang, Ying Lin, Mariam Dohadwala, Nathalie Heuzé‐Vourc'h and Li Zhu and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Seok-Chul Yang

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seok-Chul Yang South Korea 15 774 745 347 285 237 23 1.6k
Gordana Konjević Serbia 26 1.2k 1.5× 665 0.9× 473 1.4× 57 0.2× 136 0.6× 69 2.0k
Elias Gounaris United States 18 719 0.9× 411 0.6× 637 1.8× 72 0.3× 89 0.4× 27 1.5k
JI Kurland United States 12 722 0.9× 245 0.3× 343 1.0× 322 1.1× 125 0.5× 12 1.5k
S. Hauptmann Germany 20 176 0.2× 346 0.5× 668 1.9× 162 0.6× 128 0.5× 50 1.5k
Maya Gulubova Bulgaria 21 499 0.6× 500 0.7× 450 1.3× 49 0.2× 138 0.6× 107 1.5k
Wen‐Jye Lin Taiwan 26 746 1.0× 473 0.6× 998 2.9× 56 0.2× 576 2.4× 43 2.2k
Meri Najdovska Australia 14 703 0.9× 702 0.9× 540 1.6× 40 0.1× 176 0.7× 16 1.7k
Shuli Zhao China 27 723 0.9× 489 0.7× 1.1k 3.2× 59 0.2× 139 0.6× 78 2.1k
Masashi Shiina Japan 10 469 0.6× 251 0.3× 470 1.4× 92 0.3× 81 0.3× 12 1.3k
Ken‐ichi Kozaki Japan 21 134 0.2× 312 0.4× 906 2.6× 209 0.7× 178 0.8× 34 1.5k

Countries citing papers authored by Seok-Chul Yang

Since Specialization
Citations

This map shows the geographic impact of Seok-Chul Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seok-Chul Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seok-Chul Yang more than expected).

Fields of papers citing papers by Seok-Chul Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seok-Chul Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seok-Chul Yang. The network helps show where Seok-Chul Yang may publish in the future.

Co-authorship network of co-authors of Seok-Chul Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Seok-Chul Yang. A scholar is included among the top collaborators of Seok-Chul Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seok-Chul Yang. Seok-Chul Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jake June-Koo, Tae Min Kim, Youngil Koh, et al.. (2012). Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. Lung Cancer. 77(2). 460–463. 78 indexed citations
2.
Lee, Se‐Hoon, Tae Min Kim, Dong‐Wan Kim, et al.. (2012). Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer. 77(3). 572–577. 54 indexed citations
3.
Kim, Jeongeun, Sukwha Kim, Hee Chan Kim, et al.. (2012). Effects of Consumer-Centered u-Health Service for the Knowledge, Skill, and Attitude of the Patients With Chronic Obstructive Pulmonary Disease. CIN Computers Informatics Nursing. 30(12). 661–671. 11 indexed citations
4.
Kim, Kyoung Hee, Tae Yun Park, Eun Sun Kim, et al.. (2012). Clinical Features of Patients on Home Oxygen Therapy Due to Chronic Respiratory Failure at One University Hospital. The Korean Journal of Internal Medicine. 27(3). 311–311. 4 indexed citations
5.
Park, Tae Yun, Kyung‐Hee Kim, Ji Yeon Lee, et al.. (2012). Prognosis in Patients Having Chronic Obstructive Pulmonary Disease with Significant Coronary Artery Lesion Angina. The Korean Journal of Internal Medicine. 27(2). 189–189. 1 indexed citations
6.
Park, Jong Sun, Dong-Wan Kim, Jinwoo Lee, et al.. (2011). Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients. Respiratory Medicine. 106(3). 443–450. 22 indexed citations
7.
Kim, Shin‐Hee, et al.. (2010). Determination of Azelastine in Human Plasma by Validated Liquid Chromatography Coupled to Tandom Mass Spectrometry (LC-ESI/MS/MS) for the Clinical Studies. International Journal of Biomedical Science. 6(2). 120–127. 14 indexed citations
8.
Park, Jong Sun, Jeong‐Seon Ryu, Sang‐Min Lee, et al.. (2010). Influence of Additional Post-Bronchoscopy Visit on Patient Satisfaction after Flexible Bronchoscopy. The Korean Journal of Internal Medicine. 25(4). 392–392. 4 indexed citations
9.
Kim, Shin‐Hee, et al.. (2010). Determination of Azelastine in Human Plasma by Validated Liquid Chromatography Coupled to Tandom Mass Spectrometry (LC-ESI/MS/MS) for the Clinical Studies.. PubMed. 6(2). 120–7. 9 indexed citations
10.
Kim, Seo Yun, Ju‐Seop Kang, Sang‐Min Lee, et al.. (2009). TREATMENT OUTCOME AND ADVERSE EFFECT IN ELDERLY TUBERCULOSIS PATIENTS ACCORDING TO COMORBIDITIES. CHEST Journal. 136(4). 44S–44S. 1 indexed citations
11.
Andersson, Åsa, Seok-Chul Yang, Min Huang, et al.. (2009). IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer. The Journal of Immunology. 182(11). 6951–6958. 82 indexed citations
12.
13.
Jin, Sang‐Man, Hyun Ju Lee, Eun‐Ah Park, et al.. (2008). Frequency and predictors of miliary tuberculosis in patients with miliary pulmonary nodules in South Korea: A retrospective cohort study. BMC Infectious Diseases. 8(1). 160–160. 5 indexed citations
14.
Park, Jinhee, et al.. (2008). Quantification of isradipine in human plasma using LC–MS/MS for pharmacokinetic and bioequivalence study. Journal of Chromatography B. 877(1-2). 59–64. 21 indexed citations
15.
Lee, Jeong‐Ok, Dae-Young Kim, Joo Han Lim, et al.. (2008). Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients. Lung Cancer. 62(3). 381–384. 20 indexed citations
16.
Cui, Xiaoyan, Seok-Chul Yang, Sherven Sharma, Nathalie Heuzé‐Vourc'h, & Steven M. Dubinett. (2006). IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer. Biochemical and Biophysical Research Communications. 343(4). 995–1001. 25 indexed citations
17.
Arni, Stephan, Seok-Chul Yang, Stephan Korom, et al.. (2006). Combined CCL19/IL-7 treatment eradicates tumors in murine models of lung cancer.. 66. 1306–1306. 2 indexed citations
18.
Baratelli, Felicita, Ying Lin, Li Zhu, et al.. (2005). Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells. The Journal of Immunology. 175(3). 1483–1490. 464 indexed citations
19.
Sharma, Sherven, Seok-Chul Yang, Li Zhu, et al.. (2005). Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer. Cancer Research. 65(12). 5211–5220. 413 indexed citations
20.
Sharma, Sherven, Seok-Chul Yang, Sven Hillinger, et al.. (2003). SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.. Molecular Cancer. 2(1). 22–22. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordana Konjević Breakdown of academic impact, for papers by Elias Gounaris Breakdown of academic impact, for papers by JI Kurland Breakdown of academic impact, for papers by S. Hauptmann Breakdown of academic impact, for papers by Maya Gulubova Breakdown of academic impact, for papers by Wen‐Jye Lin Breakdown of academic impact, for papers by Meri Najdovska Breakdown of academic impact, for papers by Shuli Zhao Breakdown of academic impact, for papers by Masashi Shiina Breakdown of academic impact, for papers by Ken‐ichi Kozaki
Rankless by CCL
2026